Drug-target interactions that involve the replacement or displacement of magnesium ions

Bioorg Med Chem Lett. 2017 Dec 15;27(24):5355-5372. doi: 10.1016/j.bmcl.2017.11.002. Epub 2017 Nov 10.

Abstract

Metal ions play important roles in protein and RNA structure and function and the construction of ligands frequently focuses on the exploitation of functionality designed to engage a metal. However, there are circumstances where functionality can be incorporated into a ligand to emulate the metal ion, allowing target engagement by displacing or replacing the metal and directly interacting with the metal-binding elements in the target. In this Digest, we illustrate protein and RNA modulators that exploit this design principle, with all of the examples based on the displacement or replacement of a magnesium ion, and which can confer a potency advantage. Moreover, this approach relies upon an inversion of the physical chemical properties of a more conventional metal-binding ligand.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / metabolism
  • Binding Sites
  • Humans
  • Magnesium / chemistry*
  • Magnesium / metabolism
  • Molecular Dynamics Simulation
  • Pharmaceutical Preparations / chemistry*
  • Pharmaceutical Preparations / metabolism
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex / metabolism
  • Protein Kinase Inhibitors / chemistry
  • Protein Kinase Inhibitors / metabolism
  • RNA / chemistry
  • RNA / metabolism
  • rho-Associated Kinases / chemistry
  • rho-Associated Kinases / metabolism

Substances

  • Anti-Bacterial Agents
  • Pharmaceutical Preparations
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Protein Kinase Inhibitors
  • RNA
  • rho-Associated Kinases
  • Magnesium